Long-Term Oxygen Therapy Stops the Natural Decline of Endurance in COPD Patients with Reversible Hypercapnia

Background: Respiratory muscle weakness is one of the most important causes of hypercapnia in patients with COPD. There is evidence that stable hypercapnic patients will benefit from long-term oxygen therapy (LTOT). Objectives: The prognostic role of reversible hypercapnia in COPD is still unclear. Early implementation of LTOT in these patients may influence endurance time and mortality. Methods: In this pilot study, we investigated 28 patients (26 males, 49–74 years) with COPD, advanced airflow limitation [forced expiratory volume in 1 s (percentage of predicted value) 40.8 ± 10.2] and mild hypoxaemia (pO2 66.5 ± 6.3 mm Hg). All patients had developed a moderate reversible hypercapnia during an acute exacerbation or during exercise testing (peak pCO2 48.0 ± 2.5 mm Hg). Patients were allocated randomly to a control group (n = 14) or an LTOT group (n = 14). The two groups were well matched in terms of physiological data. Lung function, endurance time (cycle ergometer), dyspnoea score, blood gases and LTOT compliance were measured at baseline and every 6 months over a period of 3 years. Results: Endurance time increased from 6.4 ± 2.7 min at baseline to 7.1 ± 2.7 min after 1 year in the LTOT group and decreased from 6.1 ± 3.0 to 4.9 ± 3.8 min in the controls (p < 0.05). After 1 year, the end-exercise dyspnoea score was significantly lower in the LTOT group (4.5 ± 1.5) than in the controls (5.7 ± 1.9). Conclusion: COPD patients with reversible hypercapnia and mild hypoxaemia benefit from LTOT in terms of endurance time and a reduction of exertional dyspnoea after 1 year.

[1]  S. M. Lee,et al.  Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. , 2001, The European respiratory journal.

[2]  S. Saryal,et al.  Distinctive features and long-term survival of reversible and chronic hypercapnic patients with COPD. , 1999, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[3]  D. Veale,et al.  Characteristics and survival of patients prescribed long-term oxygen therapy outside prescription guidelines. , 1998, The European respiratory journal.

[4]  J. Zieliński.  Long-term oxygen therapy in COPD patients with moderate hypoxaemia: does it add years to life? , 1998, The European respiratory journal.

[5]  Alison E. Ries.  Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. , 1997, Chest.

[6]  P. Macklem,et al.  Inspiratory muscle dysfunction as a cause of death in COPD patients. , 1997, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[7]  D. Górecka,et al.  Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.

[8]  J. Barberà,et al.  Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. , 1997, The European respiratory journal.

[9]  W. McNicholas,et al.  Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. , 1997, The American journal of medicine.

[10]  D. O’Donnell,et al.  Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. , 1997, American journal of respiratory and critical care medicine.

[11]  B. Dautzenberg,et al.  Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. , 1996, Chest.

[12]  W. MacNee,et al.  Review of the prescription of domiciliary long term oxygen therapy in Scotland. , 1995, Thorax.

[13]  B. Celli,et al.  Long-term oxygen therapy. , 1995, The New England journal of medicine.

[14]  F. Maltais,et al.  Functional outcome of patients with chronic obstructive pulmonary disease and exercise hypercapnia. , 1995, The European respiratory journal.

[15]  J. Jamart,et al.  Prognosis of severely hypoxemic patients receiving long-term oxygen therapy. , 1994, Chest.

[16]  W. McNicholas,et al.  Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD). , 1993, The European respiratory journal.

[17]  S. Chinn,et al.  Portable liquid oxygen and exercise ability in severe respiratory disability. , 1992, Thorax.

[18]  D. Morrison,et al.  Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. , 1992, Chest.

[19]  A. Grassino,et al.  Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[20]  N. Anthonisen,et al.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. , 1989, The American review of respiratory disease.

[21]  B. Fleury,et al.  Work of breathing in patients with chronic obstructive pulmonary disease in acute respiratory failure. , 2015, The American review of respiratory disease.

[22]  G. Borg.  Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.

[23]  Cotes Je,et al.  LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working Party , 1981, The Lancet.

[24]  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. , 1980, Annals of internal medicine.